EWTX Earnings Edgewise Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -0.46 | 2026-05-07 | 10-Q |
| FY 2025 | 2025-12-31 | -1.63 | 2026-02-26 | 10-K |
| Q3 2025 | 2025-09-30 | -1.15 | 2025-11-06 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.77 | 2025-08-07 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.43 | 2026-05-07 | 10-Q |
| FY 2025 | 2024-12-31 | -1.45 | 2026-02-26 | 10-K |
| Q3 2025 | 2024-09-30 | -1.03 | 2025-11-06 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.66 | 2025-08-07 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.33 | 2025-05-08 | 10-Q |
| FY 2025 | 2023-12-31 | -1.57 | 2026-02-26 | 10-K |
| Q3 2024 | 2023-09-30 | -1.10 | 2024-11-07 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.70 | 2024-08-08 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.36 | 2024-05-09 | 10-Q |
| FY 2023 | 2022-12-31 | -1.26 | 2024-02-22 | 10-K |
| Q3 2023 | 2022-09-30 | -0.96 | 2023-11-09 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.62 | 2023-08-10 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.30 | 2023-05-11 | 10-Q |
| FY 2022 | 2021-12-31 | -1.14 | 2023-02-23 | 10-K |
| Q3 2022 | 2021-09-30 | -0.90 | 2022-11-03 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.67 | 2022-08-04 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.